Affiliation:
1. Materias Srl, Corso N. Protopisani 50, 80146 Naples, Italy
2. Institute of Polymers, Composites and Biomaterials (IPCB), National Research Council, P.le Enrico Fermi 1, 80055 Portici, Italy
Abstract
Transdermal drug delivery systems have become an intriguing research topic in healthcare technology and one of the most frequently developed pharmaceutical products in the global market. In recent years, researchers and pharmaceutical companies have made significant progress in developing new solutions in the field. This study sheds light on current trends, collaboration patterns, research hotspots, and emerging frontiers of transdermal drug delivery. Herein, a bibliometric and patent analysis of data recovered from Scopus and The Lens databases, respectively, is reported over the last 20 years. From 2000 to 2022, the annual global publications increased from 131 in 2000 to 659 in 2022. Researchers in the United States, China, and India produced the highest number of publications. Likewise, most patent applications have been filed in the USA, China, and Europe. The recovered patents are 7275, grouped into 2997 patent families, of which 314 were granted. This study could support the work of decision-makers, scientific managers, or scientists to create new business opportunities or save money, time, and intellectual capital, thereby defining when a research or technology project should be a priority or not.
Reference99 articles.
1. (2003). Transdermal Drug Delivery, Marcel Dekker Inc.. [2nd ed.].
2. Williams, A. (2003). Transdermal and Topical Drug Delivery from Theory to Clinical Practice, Pharmaceutical Press. Available online: https://www.gettextbooks.com/isbn/9780853694892/.
3. Current Status and Future Potential of Transdermal Drug Delivery;Prausnitz;Nat. Rev. Drug Discov.,2004
4. Bronaugh, R.L., and Maibach, H.I. (2005). Percutaneous Absorption, Taylor & Francis Group.
5. The Cost of Unsafe Injections;Miller;Bull. World Health Organ.,1999